The association of thyroid function with cardiac mass and left ventricular hypertrophy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 2, 2005, Pages 673-677

  Dörr, Marcus ^a   Wolff, Birger ^a   Robinson, Daniel M ^a   John, Ulrich ^a   Lüdemann, Jan ^a   Meng, Wieland ^a   Felix, Stephan B ^a   Völzke, Henry ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; EUTHYROIDISM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTHYROIDISM; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HEART; HUMANS; HYPERTHYROIDISM; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; ORGAN SIZE; PULSE; REFERENCE VALUES; SMOKING; THYROID FUNCTION TESTS; THYROTROPIN;

EID: 14044266415     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1554     Document Type: Article

References (28)

1. Polikar R, Burger A, Scherrer U, Nicod P 1993 The thyroid and the heart. Circulation 87:1435-1441
2. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
3. Kahaly G, Kampmann C, Mohr-Kahaly S 2002 Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 12:473-481
4. Parle J, Maisonneuve P, Sheppard M, Boyle P, Franklyn J 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
5. Völzke H, Lüdemann J, Robinson D, Spiecker K, Schwahn C, Kramer A, John U, Meng W 2003 The prevalence of undiagnosed thyroid disorder in a previously iodine-deficient area. Thyroid 13:803-810
6. Kannel W, Cobb J 1992 Left ventricular hypertrophy and mortality: results from the Framingham Study. Cardiology 81:291-298
7. Haider A, Larson M, Benjamin E, Levy D 1998 Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Cardiol 32:1454-1459
8. Shirani J, Barron M, Pierre-Louise M, Roberts W 1993 Congestive heart failure, dilated cardiac ventricles, and sudden death in hyperthyroidism. Am J Cardiol 72:365-368
9. Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T 1999 Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol 160:43-47
10. Petretta M, Bonaduce D, Spinelli L, Vicario M, Nuzzo V, Marciano F, Camuso P, De Sanctis V, Lupoli G 2001 Cardiovascular hemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol 145:691-696
11. Degens H, Gilde A, Lindhout M, Willemsen P, Van der Vusse G, Van Bilsen M 2002 Functional and metabolic adaption of the heart to prolonged thyroid hormone treatment. Am J Physiol Heart Circ Physiol 284:H108-H115
12. Hu L, Benvenuti L, Liberti E, Carneiro-Ramos M, Barreto-Chaves M 2003 Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol 285:R1473-R1480
13. Donatelli M, Assennato P, Abbadi V, Bucalo ML, Compagno V, Lo Vecchio S, Messina L, Russo V, Schembri A, Torregrossa V, Licata G 2003 Cardiac changes in subclinical and overt hyperthyroid women: retrospective study. Int J Cardiol 90:159-164
14. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense H, Haerting J, Willich S, Kessler C 2001 Study of health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz-Präventivmed 46:186-194
15. Meng W, Schindler A 1998 Iodine supply in Germany. WHO/EURO/NUT98 1:21-27
16. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP 1987 Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59:956-960
17. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481-493
18. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499
19. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, Sacca L, Bellastella A, Lombardi G 1993 Cardiac effects of long term thyrotropin- suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-338
20. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC 2001 Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89:591-598
21. Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, Salvatore M, Sacca L 1996 Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 81:4224-4228
22. Shapiro LE, Sievert R, Ong L, Ocampo EL, Chance RA, Lee M, Nanna M, Ferrick K, Surks MI 1997 Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab 82:2592-2595
23. Biondi B, Palmieri E, Lombardi G, Fazio S 2002 Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914
24. Biondi B, Palmieri E, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G, Perticone F 2000 Endogenous subclinical hyperthyroidism effects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85:4701-4705
25. Sgarbi J, Villaca F, Garbeline B, Villar H, Romaldini J 2003 The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab 88:1672-1677
26. Coca A, Gabriel R, de la Figuera M, Lopez-Sendon JL, Fernandez R, Sagastagoitia JD, Garcia JJ, Barajas R 1999 The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. Ventriculo Izquierdo Tension Arterial Espana. J Hypertens 17:1471-1480
27. Schirmer H, Lunde P, Rasmussen K 1999 Prevalence of left ventricular hypertrophy in a general population: The Tromso Study. Eur Heart J 20:429-438
28. Kuch B, Hense HW, Gneiting B, Doring A, Muscholl M, Brockel U, Schunkert H 2000 Body composition and prevalence of left ventricular hypertrophy. Circulation 102:405-410